1. Home
  2. LEGN vs RRC Comparison

LEGN vs RRC Comparison

Compare LEGN & RRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • RRC
  • Stock Information
  • Founded
  • LEGN 2014
  • RRC 1976
  • Country
  • LEGN United States
  • RRC United States
  • Employees
  • LEGN N/A
  • RRC N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • RRC Oil & Gas Production
  • Sector
  • LEGN Health Care
  • RRC Energy
  • Exchange
  • LEGN Nasdaq
  • RRC Nasdaq
  • Market Cap
  • LEGN 7.0B
  • RRC 8.0B
  • IPO Year
  • LEGN 2020
  • RRC N/A
  • Fundamental
  • Price
  • LEGN $32.38
  • RRC $39.00
  • Analyst Decision
  • LEGN Strong Buy
  • RRC Hold
  • Analyst Count
  • LEGN 13
  • RRC 18
  • Target Price
  • LEGN $79.42
  • RRC $42.00
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • RRC 2.9M
  • Earning Date
  • LEGN 05-13-2025
  • RRC 04-22-2025
  • Dividend Yield
  • LEGN N/A
  • RRC 0.92%
  • EPS Growth
  • LEGN N/A
  • RRC N/A
  • EPS
  • LEGN N/A
  • RRC 1.11
  • Revenue
  • LEGN $627,241,000.00
  • RRC $2,610,836,000.00
  • Revenue This Year
  • LEGN $65.96
  • RRC $34.77
  • Revenue Next Year
  • LEGN $52.55
  • RRC $8.93
  • P/E Ratio
  • LEGN N/A
  • RRC $35.01
  • Revenue Growth
  • LEGN 119.97
  • RRC 12.00
  • 52 Week Low
  • LEGN $29.27
  • RRC $27.29
  • 52 Week High
  • LEGN $60.87
  • RRC $41.95
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 45.13
  • RRC 66.15
  • Support Level
  • LEGN $30.25
  • RRC $33.42
  • Resistance Level
  • LEGN $35.81
  • RRC $35.31
  • Average True Range (ATR)
  • LEGN 1.43
  • RRC 1.06
  • MACD
  • LEGN -0.14
  • RRC 0.63
  • Stochastic Oscillator
  • LEGN 38.36
  • RRC 90.33

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About RRC Range Resources Corporation

Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.18 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.

Share on Social Networks: